These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 29343568)

  • 21. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.
    Wu P; Xiao W; Conlon T; Hughes J; Agbandje-McKenna M; Ferkol T; Flotte T; Muzyczka N
    J Virol; 2000 Sep; 74(18):8635-47. PubMed ID: 10954565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SUMOylation Targets Adeno-associated Virus Capsids but Mainly Restricts Transduction by Cellular Mechanisms.
    Chen Q; Njenga R; Leuchs B; Chiocca S; Kleinschmidt J; Müller M
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors.
    Yan Z; Zak R; Luxton GW; Ritchie TC; Bantel-Schaal U; Engelhardt JF
    J Virol; 2002 Mar; 76(5):2043-53. PubMed ID: 11836382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding Site.
    Huang LY; Patel A; Ng R; Miller EB; Halder S; McKenna R; Asokan A; Agbandje-McKenna M
    J Virol; 2016 Jun; 90(11):5219-5230. PubMed ID: 26962225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-Throughput
    Westhaus A; Cabanes-Creus M; Rybicki A; Baltazar G; Navarro RG; Zhu E; Drouyer M; Knight M; Albu RF; Ng BH; Kalajdzic P; Kwiatek M; Hsu K; Santilli G; Gold W; Kramer B; Gonzalez-Cordero A; Thrasher AJ; Alexander IE; Lisowski L
    Hum Gene Ther; 2020 May; 31(9-10):575-589. PubMed ID: 32000541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of gene transfer to the murine liver following intraperitoneal and intraportal delivery of hepatotropic AAV pseudo-serotypes.
    Dane AP; Wowro SJ; Cunningham SC; Alexander IE
    Gene Ther; 2013 Apr; 20(4):460-4. PubMed ID: 22895507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-Throughput Dissection of AAV-Host Interactions: The Fast and the Curious.
    Herrmann AK; Grimm D
    J Mol Biol; 2018 Aug; 430(17):2626-2640. PubMed ID: 29782834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adeno-associated virus (AAV) cell entry: structural insights.
    Meyer NL; Chapman MS
    Trends Microbiol; 2022 May; 30(5):432-451. PubMed ID: 34711462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GPR108 Is a Highly Conserved AAV Entry Factor.
    Dudek AM; Zabaleta N; Zinn E; Pillay S; Zengel J; Porter C; Franceschini JS; Estelien R; Carette JE; Zhou GL; Vandenberghe LH
    Mol Ther; 2020 Feb; 28(2):367-381. PubMed ID: 31784416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tracking Adeno-Associated Virus Capsid Evolution by High-Throughput Sequencing.
    de Alencastro G; Pekrun K; Valdmanis P; Tiffany M; Xu J; Kay MA
    Hum Gene Ther; 2020 May; 31(9-10):553-564. PubMed ID: 32024384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive biophysical characterization of AAV-AAVR interaction uncovers serotype- and pH-dependent interaction.
    Fu Y; Choudhary D; Liu N; Moon Y; Abdubek P; Sweezy L; Rosconi M; Palackal N; Pyles E
    J Pharm Biomed Anal; 2023 Sep; 234():115562. PubMed ID: 37441888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups.
    Rabinowitz JE; Bowles DE; Faust SM; Ledford JG; Cunningham SE; Samulski RJ
    J Virol; 2004 May; 78(9):4421-32. PubMed ID: 15078923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure of the gene therapy vector, adeno-associated virus with its cell receptor, AAVR.
    Meyer NL; Hu G; Davulcu O; Xie Q; Noble AJ; Yoshioka C; Gingerich DS; Trzynka A; David L; Stagg SM; Chapman MS
    Elife; 2019 May; 8():. PubMed ID: 31115336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism.
    Shi W; Bartlett JS
    Mol Ther; 2003 Apr; 7(4):515-25. PubMed ID: 12727115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vector Affinity and Receptor Distribution Define Tissue-Specific Targeting in an Engineered AAV Capsid.
    Martino RA; Wang Q; Xu H; Hu G; Bell P; Arroyo EJ; Sims JJ; Wilson JM
    J Virol; 2023 Jun; 97(6):e0017423. PubMed ID: 37199615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids.
    Chamberlain K; Riyad JM; Weber T
    Hum Gene Ther Methods; 2016 Feb; 27(1):1-12. PubMed ID: 26757051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma.
    Thorsen F; Afione S; Huszthy PC; Tysnes BB; Svendsen A; Bjerkvig R; Kotin RM; Lønning PE; Hoover F
    J Gene Med; 2006 Sep; 8(9):1131-40. PubMed ID: 16810631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor targeting of adeno-associated virus vectors.
    Büning H; Ried MU; Perabo L; Gerner FM; Huttner NA; Enssle J; Hallek M
    Gene Ther; 2003 Jul; 10(14):1142-51. PubMed ID: 12833123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The structure of AAVrh32.33, a novel gene delivery vector.
    Mikals K; Nam HJ; Van Vliet K; Vandenberghe LH; Mays LE; McKenna R; Wilson JM; Agbandje-McKenna M
    J Struct Biol; 2014 May; 186(2):308-17. PubMed ID: 24704217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.